Skip to main content
Start Project

Sample deliverable · Regulatory Pathway Brief

The pathway, step by step.

An illustrative brief for a Class IIa wound-care device entering a Gulf market. Steps, owners, documents and a timeline estimate — the same shape your brief would take.

Related offer: $1,800 · Regulatory Pathway Brief

Anonymized example · Illustrative only

The product

What this brief covers.

Device class (illustrative)
Class IIa
Category
Wound-care device
Market (illustrative)
Gulf market
Existing approvals (illustrative)
CE marked

Anonymized example · Illustrative only

Pathway steps

Five steps. One owner per step.

  1. 01

    Classification confirmed

    Owner: manufacturer. Confirm the class against the national classification rules before anything else.

    Week 1–2 (illustrative)

  2. 02

    Local representative appointed

    Owner: GHMAP. A licensed entity that will hold the file and answer the regulator.

    Week 2–4 (illustrative)

  3. 03

    Dossier assembled

    Owner: manufacturer, compiled by GHMAP. Technical file, labeling, existing approvals and test reports.

    Week 3–8 (illustrative)

  4. 04

    Submission and review

    Owner: regulator, via local representative. Questions stop the clock; complete answers restart it.

    Month 3–6 (illustrative)

  5. 05

    Approval and listing

    Owner: local representative. Validity period starts; renewal preparation begins 6 months before expiry.

    Month 6–7 (illustrative)

Document checklist

What the dossier needs.

Required means the file does not move without it. Conditional depends on your product's history.

  • Device classification rationale

    Required

  • ISO 13485 certificate (manufacturer)

    Required

  • Existing approvals (CE / FDA), if held

    Conditional

  • Labeling in the required languages

    Required

  • Clinical evaluation summary

    Required

  • Local representative appointment letter

    Required

  • Post-market surveillance plan

    Conditional

Timeline estimate

6–7 months, if nothing stalls (illustrative).

The estimate assumes a complete dossier at first submission and a responsive local representative. The two common delays are labeling revisions and clock-stops on reviewer questions — both are within your control before filing.

Illustrative estimate for an illustrative product. Your brief carries your product’s real timeline, with assumptions stated.

Scope honesty

What this brief is not.

  • Not a regulatory approval, clearance, or certification decision — only the regulator decides.

  • Not legal advice. Regulatory strategy is confirmed with qualified counsel before filing.

  • Not a guarantee of timelines. Estimates carry stated assumptions; the regulator sets the clock.

  • Market-access content requires professional review before business use — the same review your own brief goes through.

Your market next

Get a report like this.

Bring a market, a product, and a decision you need to make. The structure above is what lands in your inbox.

Start a project